Dedicated, Exclusive, and Uniquely Effective
Anovo is thoughtfully built to support rare and orphan therapeutics. They are our singular, dedicated focus.
Anovo gives your patients the service they deserve
We'll help design, implement, and manage a program that makes a meaningful impact on the lives of patients while supporting your drug's success.
Our focus has enabled us to create a comprehensive and integrated approach – entirely in-house – that addresses every challenge, and orchestrates every moving part for manufacturers, patients, caregivers, and clinicians.
We magnify the efficiencies of our comprehensive support by working with manufacturers as their exclusive partner for the medications we support. This ensures that programs run exactly as designed, have a single point of accountability and data, and can pivot rapidly with any market change.
A Unique Approach that Delivers Extensive Benefits
3PL/
Wholesale
Model
Patient
Services
Hub
Specialty
Pharmacy
Industry-Leading Satisfaction
Anovo’s unique approach is uniquely successful.
It drives best-in-class patient experience, timely product access, and cost effectiveness – earning industry-leading satisfaction metrics from manufacturers, patients, and their caregivers.
“I have been part of numerous launches and almost each of them had some hiccup or do-over, when it came to patient services and support. This is the first launch where I received emails (on day one) that praised the process.”- CCO of leading rare disease pharmacuetical manufacturer
99%
patient satisfaction ratings over 7 years.
94%
patient reimbursement by 90 days
97%
patient adherence through 90 days
Across-the-Board Benefits
Anovo has thought of everything needed for a successful product program and leaves nothing to chance. In every aspect of your program, our dedicated, exclusive, hands-on approach delivers benefits that drive your success.
Your patient experiences and market messaging are simplified and standardized
Your payer contracting and coverage for new products happen efficiently
Your supply chain minimizes product movement and associated risks
Your data and market feedback come from a single, consistent source
Your ability to make informed and timely decisions increases
Your timeline to implement changes gets shorter
Your program’s customization and flexibility are on the table every day
Your control increases, while your financial structure, billing, and accounting get simpler
By being dedicated to one thing and doing it better than anyone else, Anovo delivers on the promise of being a true extension of your team and your business.
The Anovo Team
Leadership Team
Board of Directors
-
NABP Logo
-
URAC Seal
Specialty Pharmacy | Expires 05/01/2024
-
URAC Accredited Logo
Rare Disease Pharmacy Center of Excellence | Expires 05/01/2024
-
Joint Commission Home Care Accreditation Program Accreditation Logo
Accredited by The Joint Commission Home Care Accreditation Program
It starts with a conversation. Contact us today.
John Peters
Chief Executive Officer
Jon Peters served as Anovo’s President at its inception and founding. Previously, he was with Accredo Health Group, Inc. where he was Senior Vice President of Reimbursement and Technology. After the company was acquired by Medco in 2005, Jon served as Chief Operating Officer, and Chief Financial Officer. Prior to joining Accredo, Jon served as Chief Financial Officer and a partner at Paradigm Capital Partners, a venture capital firm. A University of Mississippi alumnus, Jon began his career at EY (formerly Ernst & Young LLP) where he was significantly involved with Accredo through its initial public offering in 1999.